Cargando…
Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816]
BACKGROUND: The morbidity and mortality associated with depression are considerable and continue to increase. Depression currently ranks fourth among the major causes of disability worldwide, after lower respiratory infections, prenatal conditions, and HIV/AIDS. Crocus sativus L. is used to treat de...
Autores principales: | Akhondzadeh, Shahin, Fallah-Pour, Hasan, Afkham, Khosro, Jamshidi, Amir-Hossein, Khalighi-Cigaroudi, Farahnaz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC517724/ https://www.ncbi.nlm.nih.gov/pubmed/15341662 http://dx.doi.org/10.1186/1472-6882-4-12 |
Ejemplares similares
-
The neuropsychotropic effects of Crocus sativus L. (saffron): an overview of systematic reviews and meta-analyses investigating its clinical efficacy in psychiatric and neurological disorders
por: Shamabadi, Ahmad, et al.
Publicado: (2022) -
Study on diuretic activity of saffron (stigma of Crocus sativus L.) Aqueous extract in rat
por: Shariatifar, Nabi, et al.
Publicado: (2014) -
Saffron (Crocus sativus L.): As an Antidepressant
por: Siddiqui, Mohammad J., et al.
Publicado: (2018) -
Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial
por: Shakiba, Mansoor, et al.
Publicado: (2018) -
Razi’s Al-Hawi and saffron (Crocus sativus): a review
por: Mollazadeh, Hamid, et al.
Publicado: (2015)